More about

Age-Related Macular Degeneration

News
January 23, 2023
1 min read
Save

Autofluorescence shows two pathways to geographic atrophy

Autofluorescence shows two pathways to geographic atrophy

Geographic atrophy could involve two separate disease pathways, one with soft drusen and one with subretinal drusenoid deposits, according to a study published in Eye.

News
January 18, 2023
1 min read
Save

Bausch + Lomb updates PreserVision AREDS 2

Bausch + Lomb updates PreserVision AREDS 2

Bausch + Lomb has launched a new formulation of PreserVision AREDS 2 Formula eye vitamins with OcuSorb, a proprietary blend of antioxidants reported to reduce the risk for progression of age-related macular degeneration.

News
January 16, 2023
1 min read
Save

AI algorithm may help predict progression of intermediate AMD to geographic atrophy

AI algorithm may help predict progression of intermediate AMD to geographic atrophy

KOLOA, Hawaii — An artificial intelligence-driven algorithm may help predict the progression of intermediate age-related macular degeneration to geographic atrophy, according to a speaker.

News
January 16, 2023
1 min read
Save

Home diagnostic devices, telehealth close treatment gap for patients with AMD

Home diagnostic devices, telehealth close treatment gap for patients with AMD

KOLOA, Hawaii — Self-operated home diagnostic devices together with digital health care providers can help close the care gap between office visits for patients with age-related macular degeneration, a speaker here said.

News
January 13, 2023
11 min read
Save

Specialists look positively at complex, dynamic landscape of wet AMD

Specialists look positively at complex, dynamic landscape of wet AMD

With emerging treatment options and technological advances that make detection and monitoring more precise, timely and easier, wet age-related macular degeneration continues to be a vibrant area of research and innovation.

News
January 13, 2023
2 min read
Save

Could biosimilars become the first-line option for AMD treatment?

Could biosimilars become the first-line option for AMD treatment?

Anti-VEGF agents have transformed retinal disease management.

News
January 04, 2023
15 min listen
Save

Dr. Mali's Top 5 Predictions in Ophthalmology for 2023

Dr. Mali's Top 5 Predictions in Ophthalmology for 2023

In this episode, I share my top five predictions for 2023 in the field of ophthalmology.

News
November 21, 2022
4 min watch
Save

VIDEO: IRIS Registry, clinical trial data used to emulate control arm for wet AMD study

VIDEO: IRIS Registry, clinical trial data used to emulate control arm for wet AMD study

In this Healio Video Perspective, Durga S. Borkar, MD, MMCi, discusses a presentation from the Retina Society meeting exploring if data from the IRIS Registry and clinical trial data could be used to simulate a control arm.

News
November 17, 2022
1 min read
Save

Subretinal drusenoid deposits linked with cardiovascular disease

Subretinal drusenoid deposits linked with cardiovascular disease

Researchers used subretinal drusenoid deposit levels to identify high-risk cardiovascular diseases in a cohort of participants with age-related macular degeneration.

News
November 16, 2022
1 min watch
Save

VIDEO: Early data on new treatments for dry AMD ‘show promise’

VIDEO: Early data on new treatments for dry AMD ‘show promise’

Anthony DeWilde OD, FAAO, director of the tele-eye imaging program at VA Kansas City Health Care, discusses a presentation at Academy that focused on geographic atrophy in age-related macular degeneration.

View more